Authors:
Wenzel, C
Dieckmann, K
Fiebiger, W
Mannhalter, C
Chott, A
Raderer, M
Citation: C. Wenzel et al., CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour, LEUK LYMPH, 42(4), 2001, pp. 823
Authors:
Hejna, M
Kostler, WJ
Raderer, M
Steger, GG
Brodowicz, T
Scheithauer, W
Wiltschke, C
Zielinski, CC
Citation: M. Hejna et al., Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial, EUR J CANC, 37(16), 2001, pp. 1994-2002
Authors:
Ulrich-Pur, H
Kornek, GV
Fiebiger, W
Gedlicka, C
Raderer, M
Lenauer, A
Depisch, D
Lang, F
Pidlich, J
Scheithauer, W
Citation: H. Ulrich-pur et al., Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy, ANN ONCOL, 12(9), 2001, pp. 1269-1272
Authors:
Raderer, M
Osterreicher, C
Machold, K
Formanek, M
Fiebiger, W
Penz, M
Dragosics, B
Chott, A
Citation: M. Raderer et al., Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease, ANN ONCOL, 12(7), 2001, pp. 937-939
Authors:
Scheithauer, W
Kornek, GV
Schuell, B
Ulrich-Pur, H
Penz, M
Raderer, M
Lang, F
Schneeweiss, B
Lenauer, A
Depisch, D
Citation: W. Scheithauer et al., Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy, ANN ONCOL, 12(5), 2001, pp. 709-714
Authors:
Penz, M
Kornek, GV
Raderer, M
Ulrich-Pur, H
Fiebiger, W
Scheithauer, W
Citation: M. Penz et al., Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy, ANN ONCOL, 12(3), 2001, pp. 421-422
Authors:
Virgolini, I
Patri, P
Novotny, C
Traub, T
Leimer, M
Fuger, B
Li, SR
Angelberger, P
Raderer, M
Wogritsch, S
Kurtaran, A
Kletter, K
Dudczak, R
Citation: I. Virgolini et al., Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr(3)-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy, ANN ONCOL, 12, 2001, pp. S41-S45
Authors:
Stummvoll, GH
Aringer, M
Machold, KP
Smolen, JS
Raderer, M
Citation: Gh. Stummvoll et al., Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms - Report of two cases and review of the literature, SC J RHEUM, 30(1), 2001, pp. 40-44
Authors:
Hejna, M
Hamilton, G
Brodowicz, T
Haberl, I
Fiebiger, WCC
Scheithauer, W
Virgolini, I
Kostler, WJ
Oberhuber, G
Raderer, M
Citation: M. Hejna et al., Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract, ANTICANC R, 21(2A), 2001, pp. 1183-1187
Authors:
Hejna, M
Fiebiger, WCC
Reiter, WJ
Raderer, M
Citation: M. Hejna et al., Spontaneous erections in a patient with erectile dysfunction after palliative chemotherapy for non-small cell lung cancer, UROL INTERN, 67(2), 2001, pp. 163-164
Authors:
Petkov, V
Ziesche, R
Mosgoeller, W
Schenk, P
Vonbank, K
Stiebellehner, L
Raderer, M
Brunner, C
Kneussl, M
Block, LH
Citation: V. Petkov et al., Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment, THORAX, 56(9), 2001, pp. 734-736
Authors:
Ulrich-Pur, H
Kornek, GV
Fiebiger, W
Schull, B
Raderer, M
Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine, ONCOL-BASEL, 60(4), 2001, pp. 313-315
Authors:
Raderer, M
Kurtaran, A
Scheithauer, W
Fiebiger, W
Weinlaender, G
Oberhuber, G
Citation: M. Raderer et al., Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid, ONCOL-BASEL, 60(2), 2001, pp. 141-145
Authors:
Welzel, N
Le, T
Marculescu, R
Mitterbauer, G
Chott, A
Pott, C
Kneba, M
Du, MQ
Kusec, R
Drach, J
Raderer, M
Mannhalter, C
Lechner, K
Nadel, B
Jaeger, U
Citation: N. Welzel et al., Templated nucleotide addition and immunoglobulin J(H)-gene utilization in t(11;14) junctions: Implications for the mechanism of translocation and theorigin of mantle cell lymphoma, CANCER RES, 61(4), 2001, pp. 1629-1636
Authors:
Scheithauer, W
Kornek, GV
Ulrich-Pur, H
Penz, M
Raderer, M
Salek, T
Haider, K
Kwasny, W
Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271
Authors:
Virgolini, I
Traub, T
Leimer, M
Novotny, C
Pangerl, T
Ofluoglu, S
Halvadjieva, E
Smith-Jones, P
Flores, J
Li, SR
Angelberger, P
Havlik, E
Andreae, F
Raderer, M
Kurtaran, A
Niederle, B
Dubczak, R
Citation: I. Virgolini et al., New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy, Q J NUCL M, 44(1), 2000, pp. 50-58